These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22093966)
1. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™). Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966 [TBL] [Abstract][Full Text] [Related]
2. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648 [TBL] [Abstract][Full Text] [Related]
3. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer. Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660 [TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer. Seitz M; Gratzke C; Schlenker B; Buchner A; Karl A; Roosen A; Singer BB; Bastian PJ; Ergün S; Stief CG; Reich O; Tilki D Urol Oncol; 2011; 29(3):295-301. PubMed ID: 19523857 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer. Smart R N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211 [TBL] [Abstract][Full Text] [Related]
14. High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer. Pavlovich CP; Cornish TC; Mullins JK; Fradin J; Mettee LZ; Connor JT; Reese AC; Askin FB; Luck R; Epstein JI; Burke HB Urol Oncol; 2014 Jan; 32(1):34.e27-32. PubMed ID: 23558161 [TBL] [Abstract][Full Text] [Related]
15. Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning. Simmons LAM; Kanthabalan A; Arya M; Briggs T; Charman SC; Freeman A; Gelister J; Jameson C; McCartan N; Moore CM; van der Muelen J; Emberton M; Ahmed HU Prostate Cancer Prostatic Dis; 2019 May; 22(2):261-267. PubMed ID: 30279583 [TBL] [Abstract][Full Text] [Related]
16. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy. Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874 [TBL] [Abstract][Full Text] [Related]
17. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy. Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414 [TBL] [Abstract][Full Text] [Related]
18. Prostate histoscanning in clinically localized biopsy proven prostate cancer: an accuracy study. Macek P; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Ahallal Y; Gaya JM; Durant M; Mascle L; Giedelman C; Lunelli L; Validire P; Nesvadba M; Cathelineau X J Endourol; 2014 Mar; 28(3):371-6. PubMed ID: 24032370 [TBL] [Abstract][Full Text] [Related]